1. Home
  2. AGIO vs INOD Comparison

AGIO vs INOD Comparison

Compare AGIO & INOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGIO
  • INOD
  • Stock Information
  • Founded
  • AGIO 2007
  • INOD 1988
  • Country
  • AGIO United States
  • INOD United States
  • Employees
  • AGIO N/A
  • INOD N/A
  • Industry
  • AGIO Biotechnology: Pharmaceutical Preparations
  • INOD EDP Services
  • Sector
  • AGIO Health Care
  • INOD Technology
  • Exchange
  • AGIO Nasdaq
  • INOD Nasdaq
  • Market Cap
  • AGIO 1.4B
  • INOD 1.6B
  • IPO Year
  • AGIO 2013
  • INOD 1993
  • Fundamental
  • Price
  • AGIO $39.05
  • INOD $49.72
  • Analyst Decision
  • AGIO Buy
  • INOD Strong Buy
  • Analyst Count
  • AGIO 6
  • INOD 4
  • Target Price
  • AGIO $58.60
  • INOD $57.50
  • AVG Volume (30 Days)
  • AGIO 602.7K
  • INOD 2.5M
  • Earning Date
  • AGIO 07-31-2025
  • INOD 07-31-2025
  • Dividend Yield
  • AGIO N/A
  • INOD N/A
  • EPS Growth
  • AGIO N/A
  • INOD 1293.88
  • EPS
  • AGIO 11.45
  • INOD 1.08
  • Revenue
  • AGIO $37,035,000.00
  • INOD $202,301,000.00
  • Revenue This Year
  • AGIO $22.30
  • INOD $44.28
  • Revenue Next Year
  • AGIO $219.19
  • INOD $22.64
  • P/E Ratio
  • AGIO $3.45
  • INOD $46.22
  • Revenue Growth
  • AGIO 25.96
  • INOD 114.21
  • 52 Week Low
  • AGIO $23.42
  • INOD $13.02
  • 52 Week High
  • AGIO $62.58
  • INOD $71.00
  • Technical
  • Relative Strength Index (RSI)
  • AGIO 70.00
  • INOD 54.82
  • Support Level
  • AGIO $34.60
  • INOD $49.41
  • Resistance Level
  • AGIO $40.06
  • INOD $53.86
  • Average True Range (ATR)
  • AGIO 1.49
  • INOD 3.84
  • MACD
  • AGIO 0.43
  • INOD -0.00
  • Stochastic Oscillator
  • AGIO 86.59
  • INOD 48.89

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

About INOD Innodata Inc.

Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.

Share on Social Networks: